China’s Mindray Rushes To Meet Demand Surge for Patient Monitors Following May Earthquake
This article was originally published in PharmAsia News
Executive Summary
BEIJING - With a spike in orders for patient monitors following China's 7.9 magnitude earthquake, Mindray Medical International has ramped up production to supply hospitals throughout the devastated region
You may also be interested in...
Chinese Mindray Sees Increased International Growth Through U.S. Datascope Acquisition
SHANGHAI - Shenzhen-based Mindray Medical International saw strong international growth through its acquisition of American Datascope's patient monitoring business in May, the company said in a second quarter earnings call Sept. 4
Chinese Mindray Sees Increased International Growth Through U.S. Datascope Acquisition
SHANGHAI - Shenzhen-based Mindray Medical International saw strong international growth through its acquisition of American Datascope's patient monitoring business in May, the company said in a second quarter earnings call Sept. 4
Tianyin Completes Government Commission For Post-quake Medicines, Expects Expanded Revenue Despite Disruption In Operation
BEIJING - Tianyin Pharmaceutical recently completed a special government commission for traditional Chinese medicines and western drugs as part of a massive relief effort following a magnitude 7.9 earthquake that ripped through the western Chinese province of Sichuan in May